Skip to main navigation
  • About
    • Our Vision
    • Our Approach
    • Our Team
  • Pipeline
    • DARE-BV1
    • OVAPRENE®
    • Sildenafil Cream, 3.6%
  • Partners
  • Consumers
  • Investors
    • Overview
    • Press Releases
    • Presentation, Events & Webcasts
    • Stock Information
      • Stock Quote & Chart
      • Historic Stock Lookup
      • Analyst Coverage
    • Financial Information
      • Financials Overview
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management
    • Contact
  • Careers
  • Contact Us
    Dare Biosciences
    • Investors
    • Press releases
    • Presentations, Events & Webcasts
    • Stock information
    • Financial Information
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Corporate governance
    • Contact

    SEC Filings

    SEC Filings

    Filing date Form Description View
    11-19-2010 D View HTML
    0001401914-10-000003.pdf
    10-13-2010 D View HTML
    0001401914-10-000002.pdf
    06-09-2010 D View HTML
    0001401914-10-000001.pdf
    07-27-2009 D View HTML
    0001401914-09-000004.pdf
    01-22-2008 REGDEX

    REGDEX

    View HTML
    05-29-2007 REGDEX

    REGDEX

    View HTML

    Pagination

    • First page « First
    • Previous page ‹ Previous
    • …
    • Page 38
    • Page 39
    • Page 40
    • Page 41
    • Page 42
    • Page 43
    • Page 44
    • Page 45
    • Current page 46

    Data provided by Kaleidoscope.

    • Request email alerts |
    • Print this page |
    • Search investor site |

    © 2021 by Daré Bioscience | Daré Bioscience® is a registered trademark of Daré Bioscience, Inc.

    Privacy Policy | Terms of Service | COI Policy |

    Scroll to top